Holen Sie sich die Stockscreener-App
1.86
3.12%
-0.06
Handel nachbörslich:
1.87
0.01
+0.54%
Schlusskurs vom Vortag:
$1.92
Offen:
$1.96
24-Stunden-Volumen:
2.94M
Relative Volume:
2.20
Marktkapitalisierung:
$302.13M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
46.50
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
+14.11%
1M Leistung:
+20.00%
6M Leistung:
+99.51%
1J Leistung:
-55.61%
1-Tages-Spanne:
$1.80
$2.10
1-Wochen-Bereich:
$1.4705
$2.10
52-Wochen-Spanne:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Vergleichen Sie IRWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.86 | 311.87M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceJuly 2025 Institutional & High Win Rate Trade Tips - newser.com
Ironwood Pharmaceuticals Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityForecast Cut & Safe Capital Allocation Plans - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Market Overview & Safe Entry Point Identification - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yield2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Rally & Advanced Technical Signal Analysis - newser.com
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leader2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Review & AI Driven Price Predictions - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunity2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.Market Sentiment Review & Weekly Hot Stock Watchlists - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025July 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current supportInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025Market Activity Summary & Real-Time Sentiment Analysis - newser.com
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performanceEarnings Risk Summary & Weekly Setup with High ROI Potential - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recovery2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.Analyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Published on: 2025-11-02 02:58:49 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 32% - 富途牛牛
Published on: 2025-11-01 04:03:50 - newser.com
Ironwood Pharmaceuticals (IRWD) Surges 28% on Strong Linzess Sal - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):